Council of the European Union decisions on designer drugs
Council of the European Union decisions on designer drugs. Council of the European Union issued a set of decisions on 7 designer drugs to make them subject to control measures and criminal provisions.
List of substances
[edit]- paramethoxymethamphetamine (PMMA)
- 2C-I
- 2C-T-2
- 2C-T-7
- 2,4,5-trimethoxyamphetamine (TMA-2)
- benzylpiperazine (BZP)
- mephedrone (4-MMC)
Decisions
[edit]- Council Decision 2002/188/JHA of 28 February 2002 concerning control measures and criminal sanctions in respect of the new synthetic drug PMMA
- Council Decision 2003/847/JHA of 27 November 2003 concerning control measures and criminal sanctions in respect of the new synthetic drugs 2C-I, 2C-T-2, 2C-T-7 and TMA-2
Decisions based on Council Decision 2005/387/JHA of 10 May 2005 on the information exchange, risk-assessment and control of new psychoactive substances:
- Council Decision 2008/206/JHA of 3 March 2008 on defining 1-benzylpiperazine (BZP) as a new psychoactive substance which is to be made subject to control measures and criminal provisions
- Council Decision 2010/759/EU of 2 December 2010 on submitting 4-methylmethcathinone (mephedrone) to control measures
Sources
[edit]See also
[edit]- Designer drugs
- Recreational drug use
- Single Convention on Narcotic Drugs
- Convention on Psychotropic Substances
- European law on drug precursors
- European Monitoring Centre for Drugs and Drug Addiction
External links
[edit]- Control measures EMCDDA
- Adopted legislation - Decisions to ban new psychoactive substances European Commission
- Substances and classifications table (31/10/2008) – European Legal Database on Drugs report on all substances controlled in at least one EU country as of 31 October 2008 in XLS format Archived 25 February 2021 at the Wayback Machine